Consistent with this theory, it has been reported that the acquisition of CAM-DR in AML cells is due to upregulation of the anti-apoptotic Bcl-2 protein induced by β1 integrin-mediated cell adhesion [1]. This evidence concerns the gene BCL2 and acute myeloid leukemia.